New molecular insights into osteosarcoma targeted therapy
Osteosarcoma is a relatively uncommon cancer, accounting for 5% of childhood cancers
and 8.9% of cancer-related deaths in children. The overall incidence is five cases per million …
and 8.9% of cancer-related deaths in children. The overall incidence is five cases per million …
New molecular insights into osteosarcoma targeted therapy
J Yang, W Zhang - Current opinion in oncology, 2013 - mdanderson.elsevierpure.com
PURPOSE OF REVIEW: Recent translational studies in osteosarcoma are discussed with
the purpose to shed light on the new molecular therapeutic targets. RECENT FINDINGS …
the purpose to shed light on the new molecular therapeutic targets. RECENT FINDINGS …
New molecular insights into osteosarcoma targeted therapy.
J Yang, W Zhang - Current Opinion in Oncology, 2013 - europepmc.org
The genetic aberrations of vascular endothelial growth factor (VEGF), mammalian target of
rapamycin, Wnt signaling pathway, the inactivation of p53, Rb, WWOX genes, and …
rapamycin, Wnt signaling pathway, the inactivation of p53, Rb, WWOX genes, and …
New molecular insights into osteosarcoma targeted therapy
J Yang, W Zhang - Current opinion in oncology, 2013 - pubmed.ncbi.nlm.nih.gov
Purpose of review Recent translational studies in osteosarcoma are discussed with the
purpose to shed light on the new molecular therapeutic targets. Recent findings The genetic …
purpose to shed light on the new molecular therapeutic targets. Recent findings The genetic …
[引用][C] New molecular insights into osteosarcoma targeted therapy
J Yang, W Zhang - Current Opinion in Oncology, 2013 - cir.nii.ac.jp